Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder

Abstract Background Stiff Person Syndrome (SPS) is an under-diagnosed disorder that affects mobility and the quality of life of affected patients. The aim of the study is to describe the natural history of SPS, the extent of accumulated disability and the associated clinical and immunological featur...

Full description

Bibliographic Details
Main Authors: Goran Rakocevic, Harry Alexopoulos, Marinos C. Dalakas
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Neurology
Subjects:
GAD
Online Access:http://link.springer.com/article/10.1186/s12883-018-1232-z
id doaj-05014eda5c374e32a46bb10d43ba5d28
record_format Article
spelling doaj-05014eda5c374e32a46bb10d43ba5d282020-11-25T01:51:06ZengBMCBMC Neurology1471-23772019-01-011911810.1186/s12883-018-1232-zQuantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorderGoran Rakocevic0Harry Alexopoulos1Marinos C. Dalakas2Department of Neurology, Thomas Jefferson UniversityNeuroimmunology Unit, Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of AthensDepartment of Neurology, Thomas Jefferson UniversityAbstract Background Stiff Person Syndrome (SPS) is an under-diagnosed disorder that affects mobility and the quality of life of affected patients. The aim of the study is to describe the natural history of SPS, the extent of accumulated disability and the associated clinical and immunological features in patients followed for up to 8 years in a single center. Methods Our collective cohort included 57 SPS patients. Additionally, 32 of these patients were examined every 6 months for a two-year period in a longitudinal study protocol, to assess disease progression using quantitative measures of stiffness and heightened sensitivity. Results The most frequent initial symptom was leg stiffness, followed by paraspinal muscle rigidity and painful spasms in 95% of the patients. Although none of the patients required assistance for ambulation during the first 2 years of disease onset, 46 patients (80%) lost the ability to walk independently during our follow-up, despite symptomatic medications. In the longitudinal cohort, the number of stiff areas increased (p < 0.0001), consistent with worsening functional status and quality of life. High-titer anti-GAD antibodies were present in serum and CSF with elevated intrathecal GAD-specific IgG synthesis, but they did not correlate with clinical severity or progression. Conclusions This large study on SPS patients, combining an eight-year follow-up at a single center by the same leading neurologist and his team, is the first to provide longitudinal data in a large patient subgroup using objective clinical measures. One of the main findings is that SPS is a progressive disease leading to physical disability over time.http://link.springer.com/article/10.1186/s12883-018-1232-zStiff person syndromeGADAutoimmune diseasesInhibitory synapses
collection DOAJ
language English
format Article
sources DOAJ
author Goran Rakocevic
Harry Alexopoulos
Marinos C. Dalakas
spellingShingle Goran Rakocevic
Harry Alexopoulos
Marinos C. Dalakas
Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
BMC Neurology
Stiff person syndrome
GAD
Autoimmune diseases
Inhibitory synapses
author_facet Goran Rakocevic
Harry Alexopoulos
Marinos C. Dalakas
author_sort Goran Rakocevic
title Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
title_short Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
title_full Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
title_fullStr Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
title_full_unstemmed Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
title_sort quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
publisher BMC
series BMC Neurology
issn 1471-2377
publishDate 2019-01-01
description Abstract Background Stiff Person Syndrome (SPS) is an under-diagnosed disorder that affects mobility and the quality of life of affected patients. The aim of the study is to describe the natural history of SPS, the extent of accumulated disability and the associated clinical and immunological features in patients followed for up to 8 years in a single center. Methods Our collective cohort included 57 SPS patients. Additionally, 32 of these patients were examined every 6 months for a two-year period in a longitudinal study protocol, to assess disease progression using quantitative measures of stiffness and heightened sensitivity. Results The most frequent initial symptom was leg stiffness, followed by paraspinal muscle rigidity and painful spasms in 95% of the patients. Although none of the patients required assistance for ambulation during the first 2 years of disease onset, 46 patients (80%) lost the ability to walk independently during our follow-up, despite symptomatic medications. In the longitudinal cohort, the number of stiff areas increased (p < 0.0001), consistent with worsening functional status and quality of life. High-titer anti-GAD antibodies were present in serum and CSF with elevated intrathecal GAD-specific IgG synthesis, but they did not correlate with clinical severity or progression. Conclusions This large study on SPS patients, combining an eight-year follow-up at a single center by the same leading neurologist and his team, is the first to provide longitudinal data in a large patient subgroup using objective clinical measures. One of the main findings is that SPS is a progressive disease leading to physical disability over time.
topic Stiff person syndrome
GAD
Autoimmune diseases
Inhibitory synapses
url http://link.springer.com/article/10.1186/s12883-018-1232-z
work_keys_str_mv AT goranrakocevic quantitativeclinicalandautoimmuneassessmentsinstiffpersonsyndromeevidenceforaprogressivedisorder
AT harryalexopoulos quantitativeclinicalandautoimmuneassessmentsinstiffpersonsyndromeevidenceforaprogressivedisorder
AT marinoscdalakas quantitativeclinicalandautoimmuneassessmentsinstiffpersonsyndromeevidenceforaprogressivedisorder
_version_ 1724998578916556800